about
Self-Perception of Swallowing-Related Problems in Laryngopharyngeal Reflux Patients Diagnosed with 24-Hour Oropharyngeal pH Monitoring.Lung diffusion capacity in children with respiratory symptoms and untreated GERDGastroesophageal reflux disease: Important considerations for the older patientsNew developments in the pathophysiology of gastro-oesophageal reflux disease (GERD): implications for patient management.Review article: supra-oesophageal manifestations of gastro-oesophageal reflux disease.Erosive esophageal reflux vs. non erosive esophageal reflux: oral findings in 71 patientsSymptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputsExtraesophageal and atypical manifestations of GERD.Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux.Extraoesophageal manifestations of gastro-oesophageal refluxOutcomes of fundoplication: causes for concern, newer options.Reflux symptom index versus reflux finding score.An association between Helicobacter pylori and upper respiratory tract disease: fact or fiction?The Role of Helicobacter pylori in Upper Respiratory System Infections: Is it More Than Colonization?Edema of the interarytenoid mucosa seen on endoscopy is related to endoscopic-positive esophagitis (EE) and is an independent predictor of EE.Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression.Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population-based study.Extraesophageal manifestations of gastroesophageal reflux disease.Lansoprazole vs. omeprazole for gastro-oesophageal reflux disease: a pH-metric comparison.Eight weeks of omeprazole 20 mg significantly reduces both laryngopharyngeal reflux and comorbid chronic rhinosinusitis signs and symptoms: Randomised, double-blind, placebo-controlled trial.Laryngoscopy findings and histological results in a rabbit gastroesophageal reflux model.Incidence of underlying laryngeal pathology in patients initially diagnosed with laryngopharyngeal reflux.
P2860
Q30388565-7378B043-B899-47E0-917A-B661F07B47B1Q33631792-4FE07A83-299C-4C3B-8B2E-A8494C61E89FQ34441786-938DBCFA-27F4-45A9-8378-EE8F34D3C82FQ35145028-7D581B77-CF0A-4D35-83CB-51E72FA07BE6Q35630064-0EA9B783-6748-4ED6-8B0C-D9AEB615CC1FQ35712490-399FB020-1CA7-47E8-9B15-A1F5D4267649Q35745029-AFE9FFB9-42A0-40A9-BBA9-13606762C3D9Q35868512-585D6583-B4D5-4087-BF35-F7F9E572940BQ36068820-4FB1E323-F731-4594-AB7A-64F0639971F1Q36257435-D395631B-86D3-40BA-A898-3CA15B6EE0D7Q36263933-2B310E5F-A9FD-4B75-8F74-77295C11E73EQ36900409-E300D6FD-75AC-4526-AAEF-077ED8FECA71Q37587254-EE4DCBC2-764A-44C2-B1BE-8EC0864083CDQ37981982-6385A827-49BC-4D78-AA41-9529725923ECQ43570981-85BD7BFF-B78A-4777-A24A-7AE2D0B53D7AQ43967099-A8F471FF-2125-4E68-830F-CBC1BAF0C125Q44002325-A0910CFE-C108-47EB-AE71-D295E641F0E0Q44403478-B738E5B5-62E9-4CD9-B209-168863A2EB5FQ45713740-12AC5BE4-71A7-409D-8F7A-BB1F602D3EF6Q48198546-9CBE13B3-3BFF-4972-8B50-F61F87483F41Q50431312-54500A7D-21AB-4EFC-AF24-6C1AC5EEE0F0Q54704368-14D0CBE4-5426-412B-AE7F-1533A8CF057B
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
ENT manifestations of gastroesophageal reflux.
@ast
ENT manifestations of gastroesophageal reflux.
@en
ENT manifestations of gastroesophageal reflux.
@nl
type
label
ENT manifestations of gastroesophageal reflux.
@ast
ENT manifestations of gastroesophageal reflux.
@en
ENT manifestations of gastroesophageal reflux.
@nl
prefLabel
ENT manifestations of gastroesophageal reflux.
@ast
ENT manifestations of gastroesophageal reflux.
@en
ENT manifestations of gastroesophageal reflux.
@nl
P2093
P1476
ENT manifestations of gastroesophageal reflux.
@en
P2093
P304
P356
10.1016/S0002-9270(00)01074-1
P407
P433
P577
2000-08-01T00:00:00Z